Genetic Testing Via Clinical Whole Exome Sequencing (WES) Is Leveraged For Healthcare More Now Than Ever


As Your Sequencing Provider We Provide

  • Clinically insightful findings and actionable recommendations
  • Quick turnaround of data and reports
  • Cost-effective data and reporting options for physicians, medical geneticists and patients



Clinical WES Provides The Right Balance Of Insights And Price

Whole Genome Sequencing (WGS) takes too long, is often cost-prohibitive, and the data needed is usually in the exonic regions.  Whole Exome Sequencing can identify genetic variants responsible for:

  • Mendelian diseases such as Huntington’s disease
  • Somatic variants linked to various cancers
  • Diseases such as Alzheimer’s and autism which have an underlying genetic component
  • Influencing an individual’s response to a specific pharmacological regimen


Let Us Help You Select And Generate The Clinical Exome Data & Reporting Options That Are Best For Your Needs

  • Robust clinical reports with variant calling and clinical recommendations
  • Specialized comparisons (Child/Mother/Father i.e. Trio, tumor-normal, etc.) available



Clinical WES Reports with Actionable Insights 

  • Primary Findings
  • Secondary Findings
  • Incidental Findings (optional)
  • Follow-up recommendations

Email us at for more information on our clinical exome sequencing, and please be sure to specify your interest in diagnostic use.